388
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The role of long-lived plasma cells in viral clearance

, & ORCID Icon
Article: 2325523 | Received 20 May 2022, Accepted 21 Feb 2024, Published online: 06 Mar 2024

References

  • Manz RA, Hauser AE, Hiepe F, et al. Maintenance of serum antibody levels. Annu Rev Immunol. 2005;23(1):367–386. doi:10.1146/annurev.immunol.23.021704.115723
  • Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 1997;388(6638):133–134. doi: 10.1038/40540
  • Slifka MK, Antia R, Whitmire JK, et al. Humoral immunity due to long-lived plasma cells. Immunity. 1998;8(3):363–372. doi: 10.1016/S1074-7613(00)80541-5
  • Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol. 1995;69(3):1895–1902. doi: 10.1128/jvi.69.3.1895-1902.1995
  • Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996;272(5258):54–60. doi: 10.1126/science.272.5258.54
  • Arce S, Cassese G, Hauser A, et al. The role of long-lived plasma cells in autoimmunity. Immunobiology. 2002;206(5):558–562. doi: 10.1078/0171-2985-00204
  • Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol. 1998;10(3):252–258. doi: 10.1016/S0952-7915(98)80162-3
  • Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14(5):315–328. doi: 10.1038/nri3665
  • Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013;31(1):163–194. doi: 10.1146/immunol.2013.31.issue-1
  • Lee HY, Topham DJ, Park SY, et al. Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol. 2009;83(14):7151–7165. doi: 10.1128/JVI.00098-09
  • Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15(3):149–159. doi: 10.1038/nri3802
  • Zens KD, Farber DL. Memory CD4 T cells in influenza. Influenza Pathogenesis Control. 2014;II:399–421. doi: 10.1007/978-3-319-11158-2
  • Stafford MA, Corey L, Cao Y, et al. Modeling plasma virus concentration during primary HIV infection. J Theor Biol. 2000;203(3):285–301. doi: 10.1006/jtbi.2000.1076
  • Nikin-Beers R, Ciupe SM. The role of antibody in enhancing dengue virus infection. Math Biosci. 2015;263:83–92. doi: 10.1016/j.mbs.2015.02.004
  • Cao P, Wang Z, Yan AW, et al. On the role of CD8+ T cells in determining recovery time from influenza virus infection. Front Immunol. 2016;7:611. doi: 10.3389/fimmu.2016.00611
  • Yan AW, Cao P, Heffernan JM, et al. Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host. J Theor Biol. 2017;413:34–49. doi: 10.1016/j.jtbi.2016.11.008
  • La Salle JP. The stability of dynamical systems. Regional Conference Series in Applied Mathematics, SIAM, Philadelphia, 1976.
  • Siegrist CA. Vaccine immunology. Vaccines. 2008;5:17–36. doi: 10.1016/B978-1-4160-3611-1.50006-4
  • Stokel-Walker C. What we know about covid-19 reinfection so far. BMJ. 2021;372:n99.
  • Yahav D, Yelin D, Eckerle I, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Inffc. 2021;27(3):315–318. doi: 10.1016/j.cmi.2020.11.028
  • Alwan NA, Johnson L. Defining long COVID: going back to the start. Med. 2021;2(5):501–504. doi: 10.1016/j.medj.2021.03.003
  • Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi: 10.1038/s41579-022-00846-2